These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Anti-human immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patients. Amado RG; Mitsuyasu RT; Rosenblatt JD; Ngok FK; Bakker A; Cole S; Chorn N; Lin LS; Bristol G; Boyd MP; MacPherson JL; Fanning GC; Todd AV; Ely JA; Zack JA; Symonds GP Hum Gene Ther; 2004 Mar; 15(3):251-62. PubMed ID: 15018734 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of in vivo HIV infection in humanized mice by gene therapy of human hematopoietic stem cells with a lentiviral vector encoding a broadly neutralizing anti-HIV antibody. Joseph A; Zheng JH; Chen K; Dutta M; Chen C; Stiegler G; Kunert R; Follenzi A; Goldstein H J Virol; 2010 Jul; 84(13):6645-53. PubMed ID: 20410262 [TBL] [Abstract][Full Text] [Related]
6. In vivo delivery of human acid ceramidase via cord blood transplantation and direct injection of lentivirus as novel treatment approaches for Farber disease. Ramsubir S; Nonaka T; Girbés CB; Carpentier S; Levade T; Medin JA Mol Genet Metab; 2008 Nov; 95(3):133-41. PubMed ID: 18805722 [TBL] [Abstract][Full Text] [Related]
7. Lentivector Knockdown of CCR5 in Hematopoietic Stem and Progenitor Cells Confers Functional and Persistent HIV-1 Resistance in Humanized Mice. Myburgh R; Ivic S; Pepper MS; Gers-Huber G; Li D; Audigé A; Rochat MA; Jaquet V; Regenass S; Manz MG; Salmon P; Krause KH; Speck RF J Virol; 2015 Jul; 89(13):6761-72. PubMed ID: 25903342 [TBL] [Abstract][Full Text] [Related]
8. In vivo selection for human and murine hematopoietic cells transduced with a therapeutic MGMT lentiviral vector that inhibits HIV replication. Davis BM; Humeau L; Dropulic B Mol Ther; 2004 Feb; 9(2):160-72. PubMed ID: 14759800 [TBL] [Abstract][Full Text] [Related]
9. Stable and functional lymphoid reconstitution in artemis-deficient mice following lentiviral artemis gene transfer into hematopoietic stem cells. Benjelloun F; Garrigue A; Demerens-de Chappedelaine C; Soulas-Sprauel P; Malassis-Séris M; Stockholm D; Hauer J; Blondeau J; Rivière J; Lim A; Le Lorc'h M; Romana S; Brousse N; Pâques F; Galy A; Charneau P; Fischer A; de Villartay JP; Cavazzana-Calvo M Mol Ther; 2008 Aug; 16(8):1490-9. PubMed ID: 18560421 [TBL] [Abstract][Full Text] [Related]
10. Stem cell transplantation in the context of HIV--how can we cure HIV infection? Bauer G; Anderson JS Expert Rev Clin Immunol; 2014 Jan; 10(1):107-16. PubMed ID: 24308835 [TBL] [Abstract][Full Text] [Related]
11. Rescue of multi-lineage hematopoiesis during HIV-1 infection by human c-mpl gene transfer and reconstitution of CD34+ progenitor cells in vivo. Zhang M; Poh TY; Louache F; Sundell IB; Yuan J; Evans S; Koka PS J Stem Cells; 2009; 4(3):161-77. PubMed ID: 20232601 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2(-/-)gammac(-/-)) mouse model. ter Brake O; Legrand N; von Eije KJ; Centlivre M; Spits H; Weijer K; Blom B; Berkhout B Gene Ther; 2009 Jan; 16(1):148-53. PubMed ID: 18668146 [TBL] [Abstract][Full Text] [Related]
14. Glycoprotein Ibalpha promoter drives megakaryocytic lineage-restricted expression after hematopoietic stem cell transduction using a self-inactivating lentiviral vector. Lavenu-Bombled C; Izac B; Legrand F; Cambot M; Vigier A; Massé JM; Dubart-Kupperschmitt A Stem Cells; 2007 Jun; 25(6):1571-7. PubMed ID: 17379771 [TBL] [Abstract][Full Text] [Related]
15. Lentivirus-mediated transduction of PKR into CD34(+) hematopoietic stem cells inhibits HIV-1 replication in differentiated T cell progeny. Dimitrova DI; Yang X; Reichenbach NL; Karakasidis S; Sutton RE; Henderson EE; Rogers TJ; Suhadolnik RJ J Interferon Cytokine Res; 2005 Jun; 25(6):345-60. PubMed ID: 15957958 [TBL] [Abstract][Full Text] [Related]
16. High levels of transgene expression following transduction of long-term NOD/SCID-repopulating human cells with a modified lentiviral vector. Gao Z; Golob J; Tanavde VM; Civin CI; Hawley RG; Cheng L Stem Cells; 2001; 19(3):247-59. PubMed ID: 11359950 [TBL] [Abstract][Full Text] [Related]
17. The Engraftment of Lentiviral Vector-Transduced Human CD34+ Cells into Humanized Mice. Kim YS; Wielgosz M; Ryu B Methods Mol Biol; 2019; 2005():91-100. PubMed ID: 31175648 [TBL] [Abstract][Full Text] [Related]
18. Preclinical studies for a phase 1 clinical trial of autologous hematopoietic stem cell gene therapy for sickle cell disease. Urbinati F; Wherley J; Geiger S; Fernandez BC; Kaufman ML; Cooper A; Romero Z; Marchioni F; Reeves L; Read E; Nowicki B; Grassman E; Viswanathan S; Wang X; Hollis RP; Kohn DB Cytotherapy; 2017 Sep; 19(9):1096-1112. PubMed ID: 28733131 [TBL] [Abstract][Full Text] [Related]